Cardinal Expects No Further Supply Disruptions In Fee-For-Service Transition
Executive Summary
Cardinal does not expect any further disruptions in product supplies while it finalizes fee-for-service contracts with manufacturers, Pharmaceutical Distribution & Provider Services CEO Mark Parrish told the Health Industry Group Purchasing Association Feb. 17
You may also be interested in...
Wholesalers Beginning To Maximize Value Of Fee-For-Service Deals
As AmerisourceBergen gains more experience with its fee-for-service distribution contracts with manufacturers, the firm is beginning to maximize the potential value of the agreements
Wholesalers Beginning To Maximize Value Of Fee-For-Service Deals
As AmerisourceBergen gains more experience with its fee-for-service distribution contracts with manufacturers, the firm is beginning to maximize the potential value of the agreements
Distribution Fees Remain Concern In ASP Reporting Despite CMS Clarification
The Centers for Medicare & Medicaid Services' position that bona fide service fees paid by manufacturers to wholesalers are exempt from average sales price calculations may not resolve problems with the fee-for-service distribution model, Sidley Austin Brown & Wood attorney William Sarraille said